Causeway Capital Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$42.5M Sell
1,107,076
-847
-0.1% -$32.5K 0.67% 36
2025
Q1
$42.9M Buy
1,107,923
+31,343
+3% +$1.21M 0.9% 29
2024
Q4
$36.4M Buy
1,076,580
+179,174
+20% +$6.06M 0.83% 35
2024
Q3
$36.7M Buy
897,406
+143,871
+19% +$5.88M 0.9% 35
2024
Q2
$29M Buy
753,535
+16,350
+2% +$629K 0.79% 42
2024
Q1
$31.6M Sell
737,185
-58,256
-7% -$2.5M 0.83% 38
2023
Q4
$29.5M Buy
795,441
+230,694
+41% +$8.55M 0.75% 42
2023
Q3
$20.5M Buy
564,747
+165,317
+41% +$5.99M 0.54% 46
2023
Q2
$14.2M Buy
399,430
+80,270
+25% +$2.86M 0.37% 55
2023
Q1
$11.4M Buy
319,160
+82,127
+35% +$2.92M 0.27% 54
2022
Q4
$8.33M Buy
237,033
+53,489
+29% +$1.88M 0.24% 62
2022
Q3
$5.4M Sell
183,544
-22,986
-11% -$677K 0.15% 67
2022
Q2
$11.2M Sell
206,530
-172
-0.1% -$9.36K 0.28% 54
2022
Q1
$11.3M Buy
206,702
+63,865
+45% +$3.48M 0.27% 52
2021
Q4
$7.87M Buy
+142,837
New +$7.87M 0.17% 62
2019
Q2
Sell
-1,138
Closed -$59K 91
2019
Q1
$59K Sell
1,138
-226,535
-100% -$11.7M ﹤0.01% 85
2018
Q4
$10.9M Sell
227,673
-84,311
-27% -$4.03M 0.13% 57
2018
Q3
$15.7M Sell
311,984
-30,837
-9% -$1.55M 0.16% 53
2018
Q2
$17.3M Sell
342,821
-393,801
-53% -$19.8M 0.17% 53
2018
Q1
$36M Buy
736,622
+232,492
+46% +$11.4M 0.39% 40
2017
Q4
$22.4M Buy
504,130
+63,402
+14% +$2.81M 0.24% 48
2017
Q3
$22.4M Buy
440,728
+100,690
+30% +$5.11M 0.25% 46
2017
Q2
$18.3M Buy
340,038
+87,626
+35% +$4.72M 0.23% 45
2017
Q1
$13.3M Buy
252,412
+16,764
+7% +$883K 0.18% 50
2016
Q4
$11M Sell
235,648
-26,287
-10% -$1.23M 0.19% 54
2016
Q3
$14.1M Sell
261,935
-1,906
-0.7% -$103K 0.26% 50
2016
Q2
$14.3M Sell
263,841
-96,483
-27% -$5.23M 0.3% 50
2016
Q1
$19.3M Sell
360,324
-54,296
-13% -$2.91M 0.44% 40
2015
Q4
$20.9M Sell
414,620
-70,432
-15% -$3.55M 0.44% 45
2015
Q3
$23.3M Buy
485,052
+78,947
+19% +$3.79M 0.47% 42
2015
Q2
$21.1M Buy
406,105
+54,414
+15% +$2.83M 0.53% 42
2015
Q1
$20.3M Buy
+351,691
New +$20.3M 0.53% 41